Abstract
Lyme disease, the multisystem infectious disease caused by the tick-borne spirochaete Borrelia burgdorferi, has been well characterised over the past quarter century. When it is disseminated, multiple organ systems can be involved, with prominent involvement of joints, heart and both the peripheral and central nervous systems. Diagnosis is based on clinical presentation, with serological confirmation of exposure, using a combination of ELISA and Western blot techniques. When central nervous system involvement is suspected, examination of spinal fluid is invaluable. Even when infection has disseminated, and has been present for extended periods of time, response to conventional antibacterial therapy is excellent in the vast majority of individuals.
Similar content being viewed by others
References
Dattwyler RJ, Volkman DJ, Luft BJ, et al. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 1988; 319: 1441–6
Dressler F, Whalen JA, Reinhardt BN, et al. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993; 167: 392–400
Ledue TB, Collins MF, Craig WY. New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol. J Clin Microbiol 1996; 34: 2343–50
Schutzer SE, Coyle PK, Reid P, et al. Borrelia burgdorferi-specific immune complexes in acute Lyme disease. JAMA 1999; 282: 1942–6
Centers for Disease Control. Lyme disease — case definition. MMWR Morb Mortal Wkly Rep 1990; 39: 20–1
Shadick NA, Phillips CB, Sangha O, et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med 1999; 131: 919–26
Seltzer EG, Gerber MA, Cartter ML, et al. Long-term outcomes of persons with Lyme disease. JAMA 2000; 283: 609–16
Halperin JJ, Luft BJ, Anand AK, et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology 1989; 39: 753–9
Halperin JJ, Luft BJ, Volkman DJ, et al. Lyme neuroborreliosis - peripheral nervous system manifestations. Brain 1990; 113: 1207–21
Garcia Monco JC, Fernandez VB, Rogers RC, et al. Borrelia burgdorferi and other related spirochetes bind to galactocerebroside. Neurology 1992; 42: 1341–8
Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. N Engl J Med 1998; 339: 216–22
Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi. N Engl J Med 1998; 339: 209–15
Halperin JJ. Treatment of neuroborreliosis. Curr Treat Neurol 1999; 1: 139–45
Eckman MH, Steere AC, Kalish RA, et al. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. N Engl J Med 1997; 337: 357–63
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Halperin, J.J. Lyme Neuroborreliosis. Mol Diag Ther 14, 257–266 (2000). https://doi.org/10.2165/00023210-200014040-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00023210-200014040-00002